Catalyst Event
Exelixis Inc (EXEL) · Earnings Release
From KEDI Global Longevity Bio Index (KGLB)
5/5/2026, 12:00:00 AM
Exelixis is scheduled to release its first quarter 2026 financial results after the market closes on May 5, 2026. Analysts forecast earnings of $0.76 per share and revenue of $608.93 million for the quarter, scheduled. Importance is Medium as earnings releases typically result in price movements exceeding 5%.
Korean Translation
엑셀리식스는 2026년 5월 5일 장 마감 후 2026년 1분기 재무 실적을 발표할 예정임. 분석가들은 해당 분기에 주당 0.76달러의 순이익과 6억 893만 달러의 매출을 기록할 것으로 전망함. 실적 발표는 통상 5% 이상의 주가 변동을 수반하므로 중요도를 'Medium'으로 예상함. 예정됨.
Related Recent Events
Biogen Inc (BIIB) · Other
FDA PDUFA target action date for LEQEMBI's subcutaneous autoinjector formulation (IQLIK SC-AI) for initiation dosing, a potential new administration option for the Alzheimer's disease treatment, scheduled for 2026-05-24. High impact expected due to the significant market potential of the Alzheimer's treatment.
5/24/2026, 12:00:00 AM
Thermo Fisher Scientific Inc (TMO) · Other
An Investor Day is scheduled for May 20, 2026, where senior management will provide presentations scheduled.
5/20/2026, 12:00:00 AM
Takeda Pharmaceutical Co Ltd (TAK) · Earnings Release
Takeda is scheduled to announce its financial results for the full fiscal year 2025 (ending March 31, 2026) on May 13, 2026. High importance is estimated as earnings reports for major pharmaceutical firms often trigger price movements exceeding 10% based on guidance. This event is scheduled.
5/13/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Q1 2026 earnings release is scheduled. Earnings announcements typically result in >5% price impact, scheduled.
5/7/2026, 12:00:00 AM
Viatris Inc (VTRS) · Earnings Release
Viatris is scheduled to report its first quarter 2026 financial results on May 7, 2026, with an estimated price impact of over 5% based on historical earnings volatility scheduled.
5/7/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Earnings Release
Novo Nordisk is scheduled to announce its first quarter 2026 financial results. Low importance as it is a routine earnings call, scheduled.
5/6/2026, 12:00:00 AM